Gamble Jones Investment Counsel Amgen Inc Transaction History

Gamble Jones Investment Counsel

$1.33 Billion
Q4 2022

A detailed history of Gamble Jones Investment Counsel transactions in Amgen Inc stock. As of the latest transaction made, Gamble Jones Investment Counsel holds 37,776 shares of AMGN stock, worth $11.9 Million. This represents 0.75% of its overall portfolio holdings.

Number of Shares

37,776

Previous 40,017 5.6%

Holding current value

$11.9 Million

Previous $9.02 Million 9.99%

% of portfolio

0.75%

Previous 0.73%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	SELL	$229.03 - $291.01 $513,256 - $652,153	-2,241 Reduced 5.6%	37,776 $9.92 Million
Q3 2022 Nov 03, 2022	SELL	$224.46 - $253.15 $242,865 - $273,908	-1,082 Reduced 2.63%	40,017 $9.02 Million
Q2 2022 Aug 05, 2022	BUY	$230.71 - $256.74 $151,115 - $168,164	655 Added 1.62%	41,099 $10 Million
Q1 2022 May 02, 2022	SELL	$219.27 - $242.57 $303,031 - $335,231	-1,382 Reduced 3.3%	40,444 $9.78 Million
Q4 2021 Feb 09, 2022	SELL	$198.88 - $227.6 $232,490 - $266,064	-1,169 Reduced 2.72%	41,826 $9.41 Million
Q3 2021 Nov 09, 2021	BUY	$212.27 - $248.7 $30,991 - $36,310	146 Added 0.34%	42,995 $9.14 Million
Q2 2021 Aug 06, 2021	SELL	$233.58 - $259.14 $923,808 - $1.02 Million	-3,955 Reduced 8.45%	42,849 $10.4 Million
Q1 2021 May 10, 2021	BUY	$221.91 - $258.6 $86,988 - $101,371	392 Added 0.84%	46,804 $11.6 Million
Q4 2020 Feb 10, 2021	BUY	$216.38 - $257.67 $232,175 - $276,479	1,073 Added 2.37%	46,412 $10.7 Million
Q3 2020 Nov 10, 2020	SELL	$234.65 - $260.95 $54,438 - $60,540	-232 Reduced 0.51%	45,339 $11.5 Million
Q2 2020 Aug 19, 2020	SELL	$197.81 - $242.74 $172,688 - $211,912	-873 Reduced 1.88%	45,571 $10.7 Million
Q1 2020 May 08, 2020	BUY	$182.24 - $241.7 $142,511 - $189,009	782 Added 1.71%	46,444 $9.42 Million
Q4 2019 Feb 10, 2020	BUY	$189.21 - $243.2 $41,436 - $53,260	219 Added 0.48%	45,662 $11 Million
Q3 2019 Nov 04, 2019	BUY	$174.11 - $208.62 $375,381 - $449,784	2,156 Added 4.98%	45,443 $8.79 Million
Q2 2019 Aug 20, 2019	BUY	$166.7 - $195.41 $298,226 - $349,588	1,789 Added 4.31%	43,287 $7.98 Million
Q1 2019 May 02, 2019	BUY	$180.87 - $203.88 $263,708 - $297,257	1,458 Added 3.64%	41,498 $7.88 Million
Q4 2018 Feb 04, 2019	BUY	$178.4 - $208.25 $272,773 - $318,414	1,529 Added 3.97%	40,040 $7.8 Million
Q3 2018 Nov 06, 2018	BUY	$185.29 - $208.89 $178,434 - $201,161	963 Added 2.56%	38,511 $7.98 Million
Q2 2018 Aug 03, 2018	BUY	$166.05 - $186.51 $7,140 - $8,019	43 Added 0.11%	37,548 $6.93 Million
Q1 2018 May 10, 2018	BUY	$169.43 - $198.0 $173,496 - $202,752	1,024 Added 2.81%	37,505 $6.39 Million
Q4 2017 Feb 06, 2018	SELL	$168.79 - $188.59 $47,767 - $53,370	-283 Reduced 0.77%	36,481 $6.34 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $6.15 Million - $7.02 Million	36,764	36,764 $6.86 Million

Others Institutions Holding AMGN

# of Institutions

3,075

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamble Jones Investment Counsel, based on Form 13F filings with the SEC.

News

Stay updated on Gamble Jones Investment Counsel with notifications on news.

Account

Gamble Jones Investment Counsel Amgen Inc Transaction History